TABITHA TRANSUE: Open Payments
NPI 1689398232 · ROSWELL, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,607 in 57 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $2,856 · 2025 $1,607
Food & beverage: $1,527Education: $80
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 7 | $348 |
| Organon LLC | 4 | $265 |
| Arcutis Biotherapeutics, Inc. | 14 | $203 |
| UCB, Inc. | 16 | $190 |
| Janssen Scientific Affairs, LLC | 1 | $123 |
| Janssen Biotech, Inc. | 5 | $116 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $112 |
| GENZYME CORPORATION | 3 | $107 |
| Novartis Pharmaceuticals Corporation | 1 | $86 |
| ABBVIE INC. | 2 | $43 |
Products named: NEMLUVIO, VTAMA, TREMFYA, Zoryve, Bimzelx, ILUMYA, DUPIXENT, SKYRIZI.
Industry payments across GA — which companies pay providers there.
